Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Techniques & End-User The global breast lesion localization methods market will witness a robust CAGR of 13.57%, valued at $966.56 million in 2021, expected to appreciate and reach $3038 million by 2030, confirms Strategic Market Research. Breast lesion is an unusual breast tissue change that mainly occurs due to an injury or disease. These procedures are used to locate abnormalities in the breasts, such as a tumor or a lump. The surgeon must choose an appropriate localization method based on various factors, including the patient's average age, the length of the procedure, its effectiveness, the cost of surgery, its safety, and its convenience of use. Various types of breast lesion localization procedures are employed worldwide to detect lumps or tumors in the breast. Wire localization radiology, radioisotope localization, savi scout localization, agreed localization, Preoperative radioactive seed localization, RFID breast localization, magnetic seed localization, radio-guided occult lesion localization, and Chemotherapy are technologies used for localizing breast lesions. Breast Cancer Organization published data in 2018, i.e. 266,120 new cases of invasive breast cancer were reported, along with 63,960 new cases of non-invasive breast cancer were detected. World Health Organization (WHO) mentioned in a report that breast cancer is the most common cancer among women worldwide. Around 2.1 million women are diagnosed each year, and approximately 627,000 women died from breast cancer in 2018. Considering the above statistics, the market for breast lesion localization methods will multiply during the forecast period. Impact of Covid-19 pandemic on Breast Lesion Localization Methods Market The Covid-19 pandemic did not have a severe impact on the market in 2020-2021. But, on the other hand, routine-wise, hospital breast cancer screening and annual screening programs have been halted in various countries to maintain social distancing regulations and reduce the patient flow in the health care facilities. Furthermore, non-essential treatments and surgeries are postponed for the post-lockdown period. Market Drivers Breast lesions are caused by various reasons, including increased use of contraceptive tablets and a growing number of women having breast enlargements. Moreover, the rising prevalence of breast disorders such as breast cancer and cysts is fueling the market's growth. Factors responsible for driving the market growth include, the rising prevalence of breast cancer and expanding breast cancer surgeries, increased government and non-government reimbursement policies, and increasing awareness among people about the breast cancer diagnosis. Breast cancer cases are increasing worldwide, and hence the necessity for early detection is increasing. Breast cancer is the most common cancer in women, and its rising frequency is predicted to fuel the overall market growth. Market Restraint The global market is being hampered by the stringent rules for product approval processes, the expensive costs of innovative devices, and a shortage of oncologists and competent experts in various developing nations. Along with this, the regulatory concerns in breast localization and product failures may impede the market's growth. Market Opportunity Various governments are actively investing in the expansion and modernization of healthcare infrastructure, creating opportunities for the market players. Also, continuous technological advancements and raising public awareness of breast cancer detection offer favourable growth opportunities for the market. Market Analysis Of Different Segments Covered in the Report By Techniques Electromagnetic localization Wire Localization Magnetic localization Radioisotope localization Others By Usage Sentinel lymph node identification Tumor identification Lumpectomy By End-User Diagnostics Centres Oncology Clinics Hospitals Others Regional Coverage Analysis North America US. Canada Mexico Europe Germany France Italy Switzerland UK. Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA Type Analysis & Insights The 'wire localization' market segment possesses the most significant market proportion. It is due to its accuracy in abnormal tissue localization processes. Over the forecasted period, the radioisotope market segment is predicted to significantly increase as it is one of the latest procedures for preoperative localization of non-palpable, suspicious lesions. Also, it is a successful, safe, and frequently used procedure. A non-palpable breast mass cannot be felt during a clinical examination of the breast but can be detected with ultrasound, mammography, or MRI. According to the US National Library of Medicine and National Institute of Health, breast nodules develop into cancer in 20 to 30 % of people with non-palpable breast lumps. Moreover, the magnetic tracer is predicted to increase at the quickest rate due to improved efficiency, with a CAGR of 14% over the projected period. Usage Analysis & Insights The 'Tumour Identification' market segment dominates the market with an overall breast lesion localization methods market share of $ 543.1 million in 2020. 'Sentinel lymph node identification is predicted to expand at the fastest pace throughout the projected period due to the rising acceptance of SLNB as a first-line diagnostic approach for breast cancer staging. Also, it is more sensitive and produces less morbidity than early breast cancer staging techniques. End-User Analysis & Insights Between 2021 and 2028, the Hospitals segment is predicted to account for the largest revenue share of USD 596.2 million among the end-user market segments. Increasing acceptance of advanced breast lesion localization procedures, rising breast cancer prevalence, and the availability of experienced specialists are all driving the growth. As a result, oncology clinics are the fastest-growing segment with a steady CAGR of 12.13%. North America is likely to hold a significant market share worldwide because of the rising frequency of breast cancer, the expansion of breast cancer surgeries, and increased awareness of early detection of breast cancer. Moreover, due to the increasing disposable income levels, high unmet clinical needs, and increased patient awareness about early detection, Asia Pacific is predicted to grow at the quickest rate of 15.3 % throughout the projection period. According to the National Breast Cancer Foundation, sixty-two % of breast cancer cases were discovered at a localized stage in 2019. Breast Lesion Localization Methods Market Competitive Landscape Analysis Key Players in the market are as follows: Argon Medical Devices Mermaid Medical A/S IZI Medical Products Becton, Dickinson, and Company Tsunami Medical Sirius Medical BV. Molli Surgical C.R. Bard, Endomagnetics SOMATEX Medical Technologies GmbH Laurane Medical Cianna Medical CP Medical BPB Medica Cianna Medical Cook Medical Intra-Medical Imaging Ranfac Corporation Leica Biosystems Health Beacons Hologic Elucent medical Surgiceye GmbH. Sirius medical Breast Lesion Localization Methods Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 966.56 Million The revenue forecast in 2030 USD 3.03 Billion Growth rate CAGR of approximately 13.57% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Usage, By End-User, By Region. By Type Electromagnetic localization, Wire Localization, Magnetic localization, Radioisotope localization, and Others. By End-User Diagnostics Centres, Oncology Clinics, Hospitals, Others. By Usage Sentinel lymph node identification, Tumor identification, and Lumpectomy. By Region North America, Europe, Asia Pacific, LAMEA. Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Argon Medical Devices, Mermaid Medical A/S, IZI Medical Products, Becton, Dickinson, and Company, Tsunami Medical, Sirius Medical BV., Molli Surgical, C.R. Bard, Endomagnetics, SOMATEX Medical Technologies GmbH, Laurane Medical, Cianna Medical, CP Medical, BPB Medica, Cianna Medical, Cook Medical, Intra-Medical Imaging, Ranfac Corporation, Leica Biosystems, Health Beacons, Hologic, Elucent medical, Surgiceye GmbH., Sirius medical. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Recent Developments On Mar 2021, the FDA approved the Sirius Pintuition for breast cancer surgery. The Sirius Pintuition uses a non-radioactive, wire-free, pinpoint method to identify the location of non-palpable breast cancers. On Apr 2020, Dilon Technologies Inc. acquired DuneMedical, which helped Dilon offer the FDA-approved devices exclusively to identify positive margins during the breast conservation surgical processes. On Feb 2019, Hologic's LOCalizer Wireless Breast Lesion Localization System achieved CE certification. In this, the clinicians will implant Hologic's LOCalizer tag into a patient's breast up to 30 days before surgery and then can use the portable, handheld scanner to pinpoint the exact site of breast lesions before removing breast tissue. The Essential Breast Lesion Localization Devices that Market Leaders Develop Name of the product Function Key Players SenoMarkUltraCor MRI Breast Tissue Marker It provides three weeks of visibility of the affected tissue in the process of ultrasonography Becton, Dickinson and Company X-Reidy Breast Lesion Localization Needle The primary use of this device is in the preoperative marking of non-palpable breast lesions. IZI Medical Products RPLN Breast Localization Needles The application of these needles is primarily to mark the exact location of the breast lesions. CP medical LOCalizer Wire-free Guidance System A miniature radiofrequency identification (RFID) tags to mark non-palpable breast lesions. Hologic Frequently Asked Question About This Report What is the Breast Lesion Localization Methods Market size in 2021? In 2021, The valuation for the Global Breast Lesion Localization Methods Market was $ 851.07 million. What is the CAGR rate for the Breast Lesion Localization Methods Market over the forecasted period? The CAGR rate for the market over the forecasted period is 13.57%. Which is the leading end-user for Breast Lesion Localization Methods Market? Hospitals are the leading end-user for the market. Who are the major players operating in the Breast Lesion Localization Methods Market? The key players operating in the Market are Argon Medical Devices, Mermaid Medical A/S, IZI Medical Products, Becton, Dickinson and Company, Tsunami Medical, Sirius Medical BV, Molli Surgical, C.R. Bard, Endomagnetics, SOMATEX Medical Technologies GmbH, Laurane Medical, Cianna Medical, CP Medical, BPB Medica, Cianna Medical, Cook Medical, Intra-Medical Imaging, Ranfac Corporation, Leica Biosystems, Health Beacons, Hologic, Surgiceye GmbH. Which Region has the most significant share of the Market of Breast Lesion Localization Methods? The North American Region has the largest Market share. Sources https://www.who.int/news-room/fact-sheets/detail/breast-cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794703/ https://www.cancer.net/cancer-types/breast-cancer/statistics https://www.sirius-medical.com/blog/news/2021/03/25/sirius-medical-announces-fda-clearance-of-sirius-pintuition-for-breast-cancer-surgerylanguageus Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.1.2.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Wire Localization to Witness Highest CAGR in Market, By Type, During Forecast Period Figure 11: Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period Figure 12: Sentinel lymph node identification for Usage to Register Highest CAGR in Market during Forecast Period Figure 13: North America to Account for Largest Share of Global Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 14: Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Breast Lesion Localization Methods Market 5.2.1 Global Market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Market, by region, 2021 - 2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global Market, by Type, 2021 - 2030 (USD Million) 5.5 End-User Analysis 5.5.1 Global Market, by End-User, 2021 - 2030 (USD Million) 5.6 Usage Segment Analysis 5.6.1 Global Market, by Usage, 2021 - 2030 (USD Million) 5.7 By Usage Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Market PEST analysis 5.10.2 Market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 16 Market Drivers and Their Impact 6.2.2 Restraints Figure 17 Market Restraints and Their Impact 6.2.3 Opportunities Figure 18 Market Opportunities and Their Impact 6.2.4 Challenges Figure 19 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 20 Value Chain Analysis: Market 6.5 Ecosystem Figure 21 Market: Ecosystem Table 3 Market: Ecosystem Figure 22 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 23 Top 24 Companies with Highest No. of Patents in Last 9 Years Figure 24 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Market 6.7 Trade Analysis Figure 25 Import Data for Electromagnetic localization, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Wire Localization, By Country, 2016–2020 (USD Thousand) Figure 26 Import Data for Magnetic localization, By Country, 2016–2020 (USD Thousand) Table 7 Import Data for Radioisotope localization, By Country, 2016–2020 (USD Thousand) Figure 27 Import Data for Others, By Country, 2016–2020 (USD Thousand) Figure 28 Export Data for Electromagnetic localization, By Country, 2016–2020 (USD Thousand) Table 8 Export Data for Wire Localization, By Country, 2016–2020 (USD Thousand) Figure 29 Export Data for Magnetic localization, By Country, 2016–2020 (USD Thousand) Table 9 Export Data for Radioisotope localization, By Country, 2016–2020 (USD Thousand) Figure 30 Export Data for Others, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 10 Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 11 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 12: Key Players market share Figure 31: Key players market share of companies 7.2 Manufacturers Breast Lesion Localization Methods Manufacturing Sites, Area Served, Product Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 13 Market, By Type, 2021–2028 (USD Million) Figure 32 Market, By Type Figure 33 Wire Localization Segment to Register Highest CAGR in Market During Forecast Period 8.3 Wire Localization 8.3.1 Wire Localization market, 2021 - 2030 (USD Million) Figure 34: Wire Localization market, 2021 - 2030 (USD Million) 8.4 Electromagnetic localization 8.4.1 Electromagnetic localization market, 2021 - 2030 (USD Million) Figure 35: Electromagnetic localization market, 2021 - 2030 (USD Million) 8.5 Magnetic localization 8.5.1 Magnetic localization market, 2021 - 2030 (USD Million) Figure 36: Magnetic localization market, 2021 - 2030 (USD Million) 8.6 Radioisotope localization 8.6.1 Radioisotope localization market, 2021 - 2030 (USD Million) Figure 37: Radioisotope localization market, 2021 - 2030 (USD Million) 8.7 Others 8.7.1 Others market, 2021 - 2030 (USD Million) Figure 38: Others market, 2021 - 2030 (USD Million) Chapter 9. Global Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 14: Market, By End-User, 2021–2028 (USD Million) Figure 39: Market, By End-User, 2021–2028 (USD Million) Figure 40: Hospitals Segment to Register Highest CAGR in Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2021 - 2030 (USD Million) Figure 41: Hospitals market, 2021 - 2030 (USD Million) 9.4 Diagnostics Centres 9.4.1 Diagnostics Centres market, 2021 - 2030 (USD Million) Figure 42: Diagnostics Centres market, 2021 - 2030 (USD Million) 9.4 Oncology Clinics 9.4.1 Oncology Clinics market, 2021 - 2030 (USD Million) Figure 43: Oncology Clinics market, 2021 - 2030 (USD Million) 9.5 Others 9.5.1 Others market, 2021 - 2030 (USD Million) Figure 44: Others market, 2021 - 2030 (USD Million) Chapter 10. Global Market: Usage Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2021-2030) Table 15: Market, By Usage, 2021–2028 (USD Million) Figure 45: Market, By Usage, 2021–2028 (USD Million) Figure 46: Sentinel lymph Segment to Register Highest CAGR in Market during Forecast Period 10.3 Sentinel lymph node identification 10.3.1 Sentinel lymph node identification market, 2021 - 2030 (USD Million) Figure 47: Sentinel lymph node identification market, 2021 - 2030 (USD Million) 10.4 Tumor identification 10.4.1 Tumor identification market, 2021 - 2030 (USD Million) Figure 48: Fungal Tumor identification market, 2021 - 2030 (USD Million) 10.5 Lumpectomy 10.5.1 Lumpectomy market, 2021 - 2030 (USD Million) Figure 49: Lumpectomy market, 2021 - 2030 (USD Million) Chapter 11. Global Breast Lesion Localization Methods Market: Regional Outlook 11.1 North America Figure 50: North America Market, By Revenue Forecast (2021-2030) 11.1.1 North America Market, by country, 2021 - 2030 (USD Million) Table 16: North America Market, by Country, 2021-2030 Figure 51: North America Market 11.1.2 North America Market, by Type, 2021 - 2030 (USD Million) Table17: North America Market, by Type, 2021 - 2030 (USD Million) Figure 52: North America Market, by Type, 2021 - 2030 (USD Million) 11.1.3 North America Market, by End-User, 2021 - 2030 (USD Million) Table 18: North America Market, by End-User, 2021 - 2030 (USD Million) Figure 53: North America Market, by End-User, 2021 - 2030 (USD Million) 11.1.4 North America Market, by Usage, 2021 - 2030 (USD Million) Table 19: North America Market, by Usage, 2021 - 2030 (USD Million) Figure 54: North America Market, by Usage, 2021 - 2030 (USD Million) 11.1.5 U.S. 11.1.5.1 U.S. Market, by Type, 2021 - 2030 (USD Million) Figure 55: U.S. Market, by Type, 2021 - 2030 (USD Million) 11.1.5.2 U.S. Market, by End-User, 2021 - 2030 (USD Million) Figure 56: U.S. Market, by End-User, 2021 - 2030 (USD Million) 11.1.5.3 U.S. Market, by Usage, 2021 - 2030 (USD Million) Figure 57: U.S. Market, by Usage, 2021 - 2030 (USD Million) 11.1.6 Canada 11.1.6.1 Canada Market, by Type, 2021 - 2030 (USD Million) Figure 58: Canada Market, by Type, 2021 - 2030 (USD Million) 11.1.6.2 Canada Market, by End-User, 2021 - 2030 (USD Million) Figure 59: Canada Market, by End-User, 2021 - 2030 (USD Million) 11.1.6.3 Canada Market, by Usage, 2021 - 2030 (USD Million) Figure 60: Canada Market, by End-User, 2021 - 2030 (USD Million) 11.1.6.4 Canada Market, by Usage, 2021 - 2030 (USD Million) Figure 61: Canada Market, by End-User, 2021 - 2030 (USD Million) 11.2 Europe Figure 62: Europe Market, By Revenue Forecast (2021-2030) 11.2.1 Europe Market, by country, 2021 - 2030 (USD Million) Table 20: Europe Market, by country, 2021 - 2030 (USD Million) Figure 63: Europe Market, by country, 2021 - 2030 (USD Million) 11.2.2 Europe Market, by Type, 2021 - 2030 (USD Million) Table 21: Europe Market, by Type, 2021 - 2030 (USD Million) Figure 64: Europe Market, by Type, 2021 - 2030 (USD Million) 11.2.3 Europe Market, by End-User, 2021 - 2030 (USD Million) Table 22: Europe Market, by End-User, 2021 - 2030 (USD Million) Figure 65: Europe Market, by End-User, 2021 - 2030 (USD Million) 11.2.4 Europe Market, by Usage, 2021 - 2030 (USD Million) Table 23: Europe Market, by Usage, 2021 - 2030 (USD Million) Figure 66: Europe Market, by Usage, 2021 - 2030 (USD Million) 11.2.5 U.K. 11.2.5.1 U.K. Market, by Type, 2021 - 2030 (USD Million) Figure 67: U.K. Market, by Type, 2021 - 2030 (USD Million) 11.2.5.2 U.K. Market, by End-User, 2021 - 2030 (USD Million) Figure 68: U.K. Market, by End-User, 2021 - 2030 (USD Million) 11.2.5.3 U.K. Market, by Usage, 2021 - 2030 (USD Million) Figure 69: U.K. Market, by Usage, 2021 - 2030 (USD Million) 11.2.6 Germany 11.2.6.1 Germany Market, by Type, 2021 - 2030 (USD Million) Figure 70: Germany Market, by Type, 2021 - 2030 (USD Million) 11.2.6.2 Germany Market, by End-User, 2021 - 2030 (USD Million) Figure 71: Germany Market, by End-User, 2021 - 2030 (USD Million) 11.2.6.3 Germany Market, by Usage, 2021 - 2030 (USD Million) Figure 72: Germany Market, by Usage, 2021 - 2030 (USD Million) 11.2.7 France 11.2.7.1 France Market, by Type, 2021 - 2030 (USD Million) Figure 73: France Market, by Type, 2021 - 2030 (USD Million) 11.2.7.2 France Market, by End-User, 2021 - 2030 (USD Million) Figure 74: France Market, by End-User, 2021 - 2030 (USD Million) 11.2.7.3 France Market, by Usage, 2021 - 2030 (USD Million) Figure 75: France Market, by Usage, 2021 - 2030 (USD Million) 11.2.8 Rest of Europe 11.2.8.1 Rest of Europe Market, by Type, 2021 - 2030 (USD Million) Figure 76: Rest of Europe Market, by Type, 2021 - 2030 (USD Million) 11.2.8.2 Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) Figure 77: Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) 11.2.8.3 Rest of Europe Market, by Usage, 2021 - 2030 (USD Million) Figure 78: Rest of Europe Market, by Usage, 2021 - 2030 (USD Million) 11.3 Asia Pacific Figure 79: Asia Pacific Market, By Revenue Forecast (2021-2030) 11.3.1 Asia Pacific Market, by country, 2021 - 2030 (USD Million) Table 24: Asia Pacific Market, by country, 2021 - 2030 (USD Million) Figure 80: Asia Pacific Market, by country, 2021 - 2030 (USD Million) 11.3.2 Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Table 25: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Figure 81: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) 11.3.3 Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) Table 26: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) Figure 82: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) 11.3.4 Asia Pacific Market, by Usage, 2021 - 2030 (USD Million) Table 27: Asia Pacific Market, by Usage, 2021 - 2030 (USD Million) Figure 83: Asia Pacific Market, by Usage, 2021 - 2030 (USD Million) 11.3.5 China 11.3.5.1 China Market, by Type, 2021 - 2030 (USD Million) Figure 84: China Market, by Type, 2021 - 2030 (USD Million) 11.3.5.2 China Market, by End-User, 2021 - 2030 (USD Million) Figure 85: China Market, by End-User, 2021 - 2030 (USD Million) 11.3.5.3 China Market, by Usage, 2021 - 2030 (USD Million) Figure 86: China Market, by Usage, 2021 - 2030 (USD Million) 11.3.6 India 11.3.6.1 India Market, by Type, 2021 - 2030 (USD Million) Figure 87: India Market, by Type, 2021 - 2030 (USD Million) 11.3.6.2 India Market, by End-User, 2021 - 2030 (USD Million) Figure 88: India Market, by End-User, 2021 - 2030 (USD Million) 11.3.6.3 India Market, by Usage, 2021 - 2030 (USD Million) Figure 89: India Market, by Usage, 2021 - 2030 (USD Million) 11.3.7 Japan 11.3.7.1 Japan Market, by Type, 2021 - 2030 (USD Million) Figure 90: Japan Market, by Type, 2021 - 2030 (USD Million) 11.3.7.2 Japan Market, by End-User, 2021 - 2030 (USD Million) Figure 91: Japan Market, by End-User, 2021 - 2030 (USD Million) 12.3.7.3 Japan Market, by Usage, 2021 - 2030 (USD Million) Figure 92: Japan Market, by Usage, 2021 - 2030 (USD Million) 11.3.8 South Korea 11.3.8.1 South Korea Market, by Type, 2021 - 2030 (USD Million) Figure 93: South Korea Market, by Type, 2021 - 2030 (USD Million) 11.3.8.2 South Korea Market, by End-User, 2021 - 2030 (USD Million) Figure 94: South Korea Market, by End-User, 2021 - 2030 (USD Million) 12.3.8.3 South Korea Market, by Usage, 2021 - 2030 (USD Million) Figure 95: South Korea Market, by Usage, 2021 - 2030 (USD Million) 11.3.9 Rest of APAC 11.3.9.1 Rest of APAC Market, by Type, 2021 - 2030 (USD Million) Figure 96 Rest of APAC Market, by Type, 2021 - 2030 (USD Million) 11.3.9.2 Rest of APAC Market, by End-User, 2021 - 2030 (USD Million) Figure 97: Rest of APAC Market, by End-User, 2021 - 2030 (USD Million) 11.3.9.3 Rest of APAC Market, by Usage, 2021 - 2030 (USD Million) Figure 98: Rest of APAC Market, by Usage, 2021 - 2030 (USD Million) 11.4 Latin America Figure 99: Latin America Market, By Revenue Forecast (2021-2030) 11.4.1 Latin America Market, by country, 2021 - 2030 (USD Million) Table 28: Latin America Market, by country, 2021 - 2030 (USD Million) Figure 100: Latin America Market, by country, 2021 - 2030 (USD Million) 11.4.2 Latin America Market, by Type, 2021 - 2030 (USD Million) Table 29: Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 101: Latin America Market, by Type, 2021 - 2030 (USD Million) 11.4.3 Latin America Market, by End-User, 2021 - 2030 (USD Million) Table 30: Latin America Market, by End-User, 2021 - 2030 (USD Million) Figure 102: Latin America Market, by End-User, 2021 - 2030 (USD Million) 11.4.4 Latin America Market, by Usage, 2021 - 2030 (USD Million) Table 31: Latin America Market, by Usage, 2021 - 2030 (USD Million) Figure 103: Latin America Market, by Usage, 2021 - 2030 (USD Million) 11.4.5 Brazil 11.4.5.1 Brazil Market, by Type, 2021 - 2030 (USD Million) Figure 104: Brazil Market, by Type, 2021 - 2030 (USD Million) 11.4.5.2 Brazil Market, by End-User, 2021 - 2030 (USD Million) Figure 105: Brazil Market, by End-User, 2021 - 2030 (USD Million) 11.4.5.3 Brazil Market, by Usage, 2021 - 2030 (USD Million) Figure 106: Brazil Market, by Usage, 2021 - 2030 (USD Million) 11.4.6 Mexico 11.4.6.1 Mexico Market, by Type, 2021 - 2030 (USD Million) Figure 107: Mexico Market, by Type, 2021 - 2030 (USD Million) 11.4.6 2 Mexico Market, by End-User, 2021 - 2030 (USD Million) Figure 108: Mexico Market, by End-User, 2021 - 2030 (USD Million) 11.4.6.3 Mexico Market, by Usage, 2021 - 2030 (USD Million) Figure 109: Mexico Market, by Usage, 2021 - 2030 (USD Million) 11.4.7 Rest of the Latin America 11.4.7.1 Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 110: Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) 11.4.7.2 Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) Figure 111: Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) 11.4.7.3 Rest of the Latin America Market, by Usage, 2021 - 2030 (USD Million) Figure 112: Rest of the Latin America Market, by Usage, 2021 - 2030 (USD Million) 11.5 MEA Figure 113: MEA Market, By Revenue Forecast (2021-2030) 11.5.1 MEA Market, by Type, 2021 - 2030 (USD Million) Figure 114: MEA Market, by Type, 2021 - 2030 (USD Million) 11.5.2 MEA Market, by End-User, 2021 - 2030 (USD Million) Figure 115: MEA Market, by End-User, 2021 - 2030 (USD Million) 11.5.3 MEA Market, by Usage, 2021 - 2030 (USD Million) Figure 116: MEA Market, by Usage, 2021 - 2030 (USD Million) Chapter 12. Competitive Landscape 12.1 Argon Medical Devices. 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 Mermaid Medical A/S. 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 IZI Medical Products. 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 Becton, Dickinson, and Company. 12.4.1 Company overview 12.4.2 Financial performance 12.4.3 Product Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 Tsunami Medical. 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 Sirius Medical BV. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 Molli Surgical. 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 C.R. Bard. 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 Endomagnetics. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 SOMATEX Medical Technologies GmbH. 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Portfolio Analysis 12.10.4 Business Strategy & Recent Development 12.11 Laurane Medical. 12.11.1 Company overview 12.11.2 Financial performance 12.11.3 Product Portfolio Analysis 12.11.4 Business Strategy & Recent Development 12.12 Cianna Medical. 12.12.1 Company overview 12.12.2 Financial performance 12.12.3 Product Portfolio Analysis 12.12.4 Business Strategy & Recent Development 12.13 CP Medical. 12.13.1 Company overview 12.13.2 Financial performance 12.13.3 Product Portfolio Analysis 12.13.4 Business Strategy & Recent Development 12.14 BPB Medica. 12.14.1 Company overview 12.14.2 Financial performance 12.14.3 Product Portfolio Analysis 12.14.4 Business Strategy & Recent Development 12.15 Cianna Medical. 12.15.1 Company overview 12.15.2 Financial performance 12.15.3 Product Portfolio Analysis 12.15.4 Business Strategy & Recent Development 12.16 Cook Medical. 12.16.1 Company overview 12.16.2 Financial performance 12.16.3 Product Portfolio Analysis 12.16.4 Business Strategy & Recent Development 12.17 Intra-Medical Imaging. 12.17.1 Company overview 12.17.2 Financial performance 12.17.3 Product Portfolio Analysis 12.17.4 Business Strategy & Recent Development 12.18 Ranfac Corporation. 12.18.1 Company overview 12.18.2 Financial performance 12.18.3 Product Portfolio Analysis 12.18.4 Business Strategy & Recent Development 12.19 Leica Biosystems. 12.19.1 Company overview 12.19.2 Financial performance 12.19.3 Product Portfolio Analysis 12.19.4 Business Strategy & Recent Development 12.20 Health Beacons. 12.20.1 Company overview 12.20.2 Financial performance 12.20.3 Product Portfolio Analysis 12.20.4 Business Strategy & Recent Development 12.21 Hologic. 12.21.1 Company overview 12.21.2 Financial performance 12.21.3 Product Portfolio Analysis 12.21.4 Business Strategy & Recent Development 12.22 Elucent medical. 12.22.1 Company overview 12.22.2 Financial performance 12.22.3 Product Portfolio Analysis 12.22.4 Business Strategy & Recent Development 12.23 Surgiceye GmbH. 12.23.1 Company overview 12.23.2 Financial performance 12.23.3 Product Portfolio Analysis 12.23.4 Business Strategy & Recent Development 12.24 Sirius medical. 12.24.1 Company overview 12.24.2 Financial performance 12.24.3 Product Portfolio Analysis 12.24.4 Business Strategy & Recent Development